High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption

被引:1
|
作者
Drouin-Chartier, Jean-Philippe [1 ,2 ,3 ]
Tremblay, Andre J. [1 ]
Bergeron, Jean [2 ,3 ]
Lamarche, Benoit [4 ]
Couture, Patrick [1 ,2 ,3 ]
机构
[1] Laval Univ, Dept Med, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
[2] Laval Univ, CHU Quebec, Dept Med, Lipid Clin, Quebec City, PQ, Canada
[3] Laval Univ, CHU Quebec, Dept Med, Lipid Res Ctr, Quebec City, PQ, Canada
[4] Laval Univ, Sch Nutr, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Homozygous familial hypercholesterolemia; Lipoprotein apheresis; Dextran sulfate adsorption; Triglyceride; LDL-Cholesterol; CORONARY-HEART-DISEASE; LDL RECEPTOR GENE; CARDIOVASCULAR-DISEASE; FRIEDEWALD FORMULA; CHOLESTEROL; PLASMA; MUTATION; HYPERLIPOPROTEINEMIA; APOLIPOPROTEIN(A); POPULATION;
D O I
10.1016/j.atherosclerosis.2018.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Maximizing the acute reduction of LDL-cholesterol (C) and lipoprotein (a) (Lp(a)) concentrations in patients with homozygous familial hypercholesterolemia (HoFH) is the main goal of lipoprotein apheresis (LA). The objective of this study was to examine how the pre-LA serum TG concentrations influence the efficacy of LA to acutely reduce LDL-C and Lp(a) concentrations in HoFH patients. Methods: Data from 1761 LA treatments of HoFH patients (n = 10) and compound heterozygous patients (n = 5) collected between 2008 and 2016 were analyzed. These data included the pre-and post-LA concentrations of LDL-C, TGs and Lp(a); volume of filtered plasma; type of LA system used (dextran sulfate adsorption (DSA) or heparin-induced extracorporeal LDL precipitation (HELP)); and interval between treatments. Results: A significant association between the pre-LA TG concentrations and acute LA-induced reduction in LDL-C, modified by the type of LA system used, was observed (p pre-LA TG quartile*LA system =.04). Using the DSA system, the acute reduction of the LDL-C concentrations was attenuated by 3.9% when the preLA TG concentrations were > 2.09 mmol/L vs. <= 0.93 mmol/L (highest vs. lowest quartiles: =59.4% vs. =63.3%, p =.007). Using the HELP system, no significant difference was observed in the reduction of LDL-C between the highest and the lowest quartiles of serum TGs (=65.8% vs. =66.4%, p =.9). No association was observed between pre-LA TG concentrations and acute LA-induced decrease in Lp(a) (p =.2). Conclusions: The efficacy of LA is inversely associated with pre-LA TG concentrations in HoFH patients who used the DSA system instead of the HELP system. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [31] Comment on "Homozygous familial hypercholesterolemia with severe involvement of the aortic valve: A sibling-controlled case study on the efficacy of lipoprotein apheresis"
    Sbrana, Francesco
    Dal Pino, Beatrice
    Bigazzi, Federico
    Sampietro, Tiziana
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (01) : 219 - 220
  • [32] Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolemia phenotype
    Fountas, E.
    Diakoumakou, O.
    Kolovou, V.
    Stratakis, S.
    Zacharis, E.
    Liberopoulos, E.
    Matsouka, F.
    Tsoutsinos, A.
    Mastorakou, I.
    Katsikas, T.
    Mavrogeni, S.
    Hatzigeorgiou, G.
    Kolovou, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3258 - 3258
  • [33] The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy
    Yamamoto, A
    Harada-Shiba, M
    Endo, M
    Kusakabe, N
    Tanioka, T
    Kato, H
    Shoji, T
    ATHEROSCLEROSIS, 2006, 186 (01) : 126 - 131
  • [34] Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
    Laura D’Erasmo
    Antonio Gallo
    Angelo Baldassare Cefalù
    Alessia Di Costanzo
    Samir Saheb
    Antonina Giammanco
    Maurizio Averna
    Alessio Buonaiuto
    Gabriella Iannuzzo
    Giuliana Fortunato
    Arturo Puja
    Tiziana Montalcini
    Chiara Pavanello
    Laura Calabresi
    Giovanni Battista Vigna
    Marco Bucci
    Katia Bonomo
    Fabio Nota
    Tiziana Sampietro
    Francesco Sbrana
    Patrizia Suppressa
    Carlo Sabbà
    Fabio Fimiani
    Arturo Cesaro
    Paolo Calabrò
    Silvia Palmisano
    Sergio D’Addato
    Livia Pisciotta
    Stefano Bertolini
    Randa Bittar
    Olga Kalmykova
    Sophie Béliard
    Alain Carrié
    Marcello Arca
    Eric Bruckert
    Orphanet Journal of Rare Diseases, 16
  • [35] Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
    D'Erasmo, Laura
    Gallo, Antonio
    Cefalu, Angelo Baldassare
    Di Costanzo, Alessia
    Saheb, Samir
    Giammanco, Antonina
    Averna, Maurizio
    Buonaiuto, Alessio
    Iannuzzo, Gabriella
    Fortunato, Giuliana
    Puja, Arturo
    Montalcini, Tiziana
    Pavanello, Chiara
    Calabresi, Laura
    Vigna, Giovanni Battista
    Bucci, Marco
    Bonomo, Katia
    Nota, Fabio
    Sampietro, Tiziana
    Sbrana, Francesco
    Suppressa, Patrizia
    Sabba, Carlo
    Fimiani, Fabio
    Cesaro, Arturo
    Calabro, Paolo
    Palmisano, Silvia
    D'Addato, Sergio
    Pisciotta, Livia
    Bertolini, Stefano
    Bittar, Randa
    Kalmykova, Olga
    Beliard, Sophie
    Carrie, Alain
    Arca, Marcello
    Bruckert, Eric
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [36] SELECTIVE REMOVAL OF APOLIPOPROTEIN-B-CONTAINING LIPOPROTEINS BY DEXTRAN SULFATE COLUMN IN HOMOZYGOUS AND HETEROZYGOUS PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    MICHISHITA, I
    MABUCHI, H
    SAKAI, T
    TAKEDA, M
    KAJINAMI, K
    ITOH, H
    WAKASUGI, T
    KOBALADZE, AS
    TAKEDA, R
    UEDA, K
    ARTIFICIAL ORGANS, 1988, 12 (04) : 358 - 358
  • [37] Single whole blood dextran sulfate adsorption favorably affects systemic oxidative balance in lipoprotein apheresis patients
    Kopprasch, S.
    Bornstein, S. R.
    Schwarz, P. E. H.
    Bergmann, S.
    Julius, U.
    Graessler, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (01) : 157 - 160
  • [38] A nation-wide survey of patients with homozygous familial hypercholesterolemia undergoing lipoprotein-apheresis in Turkey (A-HIT Registry)
    Kayikcioglu, M.
    Tokgozoglu, L.
    Yilmaz, N.
    Kaynar, L. G.
    Aktan, M.
    Durmus, R.
    Temizhan, A.
    Ozcebe, O.
    Akyol, T. K.
    Okutan, H.
    Sag, S.
    Altunkeser, B. B.
    Albayrak, D.
    Kurtoglu, E.
    Demircioglu, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 142 - 142
  • [40] Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
    Blom, Dirk J.
    Averna, Maurizio R.
    Meagher, Emma A.
    Theron, Hendrik du Toit
    Sirtori, Cesare R.
    Hegele, Robert A.
    Shah, Prediman K.
    Gaudet, Daniel
    Stefanutti, Claudia
    Vigna, Giovanni B.
    Larrey, Dominique
    Bloedon, LeAnne T.
    Foulds, Pamela
    Rader, Daniel J.
    Cuchel, Marina
    CIRCULATION, 2017, 136 (03) : 332 - 335